News Focus
News Focus
icon url

dstock07734

12/09/24 10:55 AM

#736411 RE: Horseb4CarT #736407

Horse,

If you have time, do a little forensic data analysis of the following trial. Maybe you will load more.

Why did Merck reactivate the old trial and enroll another 25 rGBM patients around the same time the combo trial was undergoing?

https://clinicaltrials.gov/study/NCT02852655?tab=history&a=14&b=15&compareMode=sideBySide#version-content-panel
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264695
https://cdn.clinicaltrials.gov/large-docs/55/NCT02852655/Prot_SAP_000.pdf

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121810



Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
https://pubmed.ncbi.nlm.nih.gov/30742122/
icon url

tryn2

12/09/24 11:53 AM

#736419 RE: Horseb4CarT #736407

Over 2 million now..
icon url

manibiotech

12/09/24 11:54 AM

#736421 RE: Horseb4CarT #736407

Yea makes sense ... pent up demand ... SP doesn't even go up by 5 cents . 
icon url

martyDg

12/09/24 12:39 PM

#736432 RE: Horseb4CarT #736407

It's a dud. It's always a dud. Why do you think we are at this level? There's been no BIG pump since the very beginning of this year.